Venizelos A, Engebrethsen C, Deng W, Geisler J, Geisler S, Iversen GT, Aas T, Aase HS, Seyedzadeh M, Steinskog ES, Myklebost O, Nakken S, Vodak D, Hovig E, Meza-Zepeda LA, Lønning PE, Knappskog S, Eikesdal HP(2022) Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy Genome Med, 14(1), 86 DOI 10.1186/s13073-022-01090-2, PubMed 35948919
Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich Det al.(2022) Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway J Transl Med, 20(1), 317 DOI 10.1186/s12967-022-03518-0, PubMed 35841045
Misund K, Hofste Op Bruinink D, Coward E, Hoogenboezem RM, Rustad EH, Sanders MA, Rye M, Sponaas AM, van der Holt B, Zweegman S, Hovig E, Meza-Zepeda LA, Sundan A, Myklebost O, Sonneveld P, Waage A(2022) Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence Leukemia, 36(7), 1887-1897 DOI 10.1038/s41375-022-01597-y, PubMed 35643867